Targeting the HOX/PBX dimer in breast cancer

The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway

(2011) K. Jin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Targeting HOX and PBX transcription factors in ovarian cancer

(2010) Richard Morgan et al.   BMC CANCER

Additive and global functions of HoxA cluster genes in mesoderm derivatives

(2010) Nicolas Di-Poï et al.   DEVELOPMENTAL BIOLOGY

Activating Transcription Factor 3 Activates p53 by Preventing E6-associated Protein from Binding to E6

(2010) Hongbo Wang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Disruption of HOX activity leads to cell death that can be enhanced by the interference of iron uptake in malignant B cells

(2010) T R Daniels et al.   LEUKEMIA

Influence of Hoxa5 on p53 Tumorigenic Outcome in Mice

(2009) Gaëlle Gendronneau et al.   AMERICAN JOURNAL OF PATHOLOGY

HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer)

(2009) L Plowright et al.   BRITISH JOURNAL OF CANCER

Hoxb7 Inhibits Transgenic HER-2/neu-Induced Mouse Mammary Tumor Onset but Promotes Progression and Lung Metastasis

(2008) H. Chen et al.   CANCER RESEARCH

Disrupting the Interaction Between HOX and PBX Causes Necrotic and Apoptotic Cell Death in the Renal Cancer Lines CaKi-2 and 769-P

(2008) Liesl Shears et al.   JOURNAL OF UROLOGY